share_log

HC Wainwright & Co. Maintains Buy on TC BioPharm (Holdings), Lowers Price Target to $7

Benzinga ·  Apr 27, 2023 06:29

HC Wainwright & Co. analyst Mitchell Kapoor maintains TC BioPharm (Holdings) (NASDAQ:TCBP) with a Buy and lowers the price target from $9 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment